Suppr超能文献

[肠球菌;感染率和抗生素耐药性增加]

[Enterococci; increase in infection rate and antibiotic resistance].

作者信息

Thompson J

机构信息

Academisch Ziekenhuis, afd. Infectieziekten, Leiden.

出版信息

Ned Tijdschr Geneeskd. 1996 Jan 20;140(3):130-3.

PMID:8618630
Abstract

Enterococci (mainly Enterococcus faecalis and E. faecium) are increasingly isolated as causative agents of infections, notably in hospitalised patients. Most infections are urinary tract infections, septicaemia and endocarditis. Dutch figures indicate that 10.8% of all bacteria isolated in seven regional microbiological laboratories were enterococci; the samples came not only from hospital infections. Of the isolates 34% were from faecal samples, 14% from urinary tract samples and 14% from genital organ samples. Antibiotic resistance is an increasing problem. Enterococci are moderately resistant to the antibiotics commonly used to treat Gram positive infections. The infections may be treated with (high dose) penicillin and (or) in combination with an aminoglycoside or with a glycopeptide. Unrestricted use of antibiotics increases the risk of resistance. Recently enterococci have been isolated which are resistant to ampicillin, gentamycin and vancomycin: such infections are virtually untreatable.

摘要

肠球菌(主要是粪肠球菌和屎肠球菌)作为感染的病原体越来越多地被分离出来,尤其是在住院患者中。大多数感染是尿路感染、败血症和心内膜炎。荷兰的数据表明,在七个地区微生物实验室分离出的所有细菌中,10.8%是肠球菌;样本不仅来自医院感染。在分离出的菌株中,34%来自粪便样本,14%来自尿路样本,14%来自生殖器官样本。抗生素耐药性是一个日益严重的问题。肠球菌对常用于治疗革兰氏阳性感染的抗生素有中度耐药性。这些感染可用(高剂量)青霉素和(或)与氨基糖苷类或糖肽类联合治疗。抗生素的无节制使用会增加耐药风险。最近分离出了对氨苄西林、庆大霉素和万古霉素耐药的肠球菌:此类感染几乎无法治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验